Skandinaviska Enskilda Banken (SEB)
ISEE

Skandinaviska Enskilda Banken (SEB)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,000
Closed -$1.53M – 1014
2023
Q2 		$1.53M Sell
39,000
-745,542
-95% -$26.3M 0.01% 613
2023
Q1 		$19.1M Sell
784,542
-6,260
-0.8% -$137K 0.13% 164
2022
Q4 		$16.9M Sell
790,802
-6,584
-0.8% -$141K 0.13% 178
2022
Q3 		$14.3M Buy
797,386
+725,155
+1,004% +$9.52M 0.11% 184
2022
Q2 		$695K Hold
72,231
– – 0.01% 761
2022
Q1 		$1.22M Buy
+72,231
New +$1.07M 0.01% 729

Skandinaviska Enskilda Banken (SEB)'s ISEE Position: Q3 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 39,000 shares — an estimated $1.53M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ISEE in Q1 2022 and held it in 6 quarters. The position peaked at $19.1M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 39,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.53M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in IVERIC bio, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s IVERIC bio, Inc. Common Stock position peaked at $19.1M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2023, filed 9 Nov 2023.